Bank Of New York Mellon Corp Vascular Biogenics Ltd. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.11 - $0.16 $4,290 - $6,240	39,000 New	39,000 $4,000
Q4 2021 Feb 11, 2022	BUY	$1.92 - $2.53 $26,880 - $35,420	14,000 Added 56.0%	39,000 $77,000
Q4 2020 Feb 09, 2021	BUY	$1.07 - $2.0 $26,750 - $50,000	25,000 New	25,000 $47,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.